ahlam1399
04-20-2016, 03:27 PM
Genmab raises 2016 guidance on strong Darzalex sales
COPENHAGEN, April 20 (Reuters) - Danish biotech companyGenmab raised its financial guidance for 2016 onWednesday due to "robust" sales of its blood cancer drugDarzalex since it was launched in...http://feeds.feedburner.com/~ff/reuters/mergersNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/mergersNews?a=qGAs28c8XeY:O8THW_IoAfs:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=qGAs28c8XeY:O8THW_IoAfs:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/mergersNews?a=qGAs28c8XeY:O8THW_IoAfs:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=qGAs28c8XeY:O8THW_IoAfs:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/mergersNews?a=qGAs28c8XeY:O8THW_IoAfs:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/mergersNews/~4/qGAs28c8XeY
COPENHAGEN, April 20 (Reuters) - Danish biotech companyGenmab raised its financial guidance for 2016 onWednesday due to "robust" sales of its blood cancer drugDarzalex since it was launched in...http://feeds.feedburner.com/~ff/reuters/mergersNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/mergersNews?a=qGAs28c8XeY:O8THW_IoAfs:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=qGAs28c8XeY:O8THW_IoAfs:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/mergersNews?a=qGAs28c8XeY:O8THW_IoAfs:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=qGAs28c8XeY:O8THW_IoAfs:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/mergersNews?a=qGAs28c8XeY:O8THW_IoAfs:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/mergersNews/~4/qGAs28c8XeY